Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.gastro.2020.06.028 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
MicroRNA-32-5p promotes the proliferation and metastasis of gastric cancer cells.
Sci Rep
January 2025
Department of Pharmacy, The Second Hospital of Shandong University, 247#, Beiyuan Street, Jinan, 250033, China.
Gastric cancer (GC) is a huge threat to global health, there is no effective treatment or just delay the progression of advanced GC until now. Micro-RNAs were reported to participate in the progression of GC. Clonal formation, MTT, caspase-3 activity, sperm DNA fragmentation, flow cytometry assay, cell adhesion, transwell assays were performed to detect the functions of miR-32-5p or anti-miR-32-5p on the growth and metastasis of GC cells.
View Article and Find Full Text PDFEndoscopic retrieval of a huge gastric trichobezoar after thermally induced cutting with a hook knife.
Endoscopy
December 2024
Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Pancreatic groove cancer with large cystic lesion.
Clin J Gastroenterol
November 2024
Division of Hepato-Biliary-Pancreatic Surgery, Department of Gastroenterological Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-Ku, Tokyo, 105-8470, Japan.
Article Synopsis
- - Groove pancreatic cancer is a malignant tumor that forms in the area where the pancreas, duodenum, and bile duct meet, and it can be difficult to differentiate from groove pancreatitis due to similar symptoms and imaging results.
- - A 54-year-old male patient experienced severe gastrointestinal symptoms and imaging showed a problematic lesion near the pancreas, but doctors were unable to confirm malignancy before surgery.
- - After surgical intervention, the diagnosis of groove pancreatic adenocarcinoma was confirmed, but despite treatment, the patient passed away 17 months later, highlighting the need to consider groove pancreatic cancer in similar cases.
Identification of lncRNA dual targeting PD-L1 and PD-L2 as a novel prognostic predictor for gastric cancer.
Front Oncol
October 2024
Health Care Center, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China.
Article Synopsis
- Breakthroughs in gastric cancer therapy using immune checkpoint inhibitors (ICIs) are limited by the challenge of achieving high response rates, necessitating the identification of novel biomarkers for immunotherapy.
- Researchers utilized data from The Cancer Genome Atlas (TCGA) to analyze differentially expressed long non-coding RNAs (lncRNAs) in gastric cancer and created competing endogenous RNA (ceRNA) networks to find significant lncRNAs.
- They identified LINC01094 as a key lncRNA linked to PD-L1 and PD-L2, with higher levels in tumor samples compared to normal tissue, correlating with more advanced tumor stages.
Two-stage endoscopic resection for a huge gastric tumor at the fornix.
VideoGIE
October 2024
Department of Gastrointestinal Endoscopy, NTT Medical Center Tokyo, Tokyo, Japan.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!